CardiologyBeginner

CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk

Calculates stroke risk for patients with atrial fibrillation.

Clinical Parameters

7 Variables

Awaiting Clinical Parameters

Configure the patient variables on the left and select Calculate Result to generate the clinical score and stratification.

Verified 2026 GuidelinesInstant Calculation
Jump to Formula & Clinical Protocol ↓
Advertisement
High Yield Prometric TopicCardiology

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Clinical Significance & Diagnostic Standard
2026 Clinical Reference

What is the CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk?

📋Clinical Summary & Definition Capsule

The CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. The CHA₂DS₂-VASc score is a clinical prediction rule for estimating the risk of stroke in patients with non-rheumatic atrial fibrillation (AF), a common and serious heart arrhythmia. Clinical scoring tools like CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

Guidelines recommend oral anticoagulation for score ≥2 in men or ≥3 in women.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk:

Sum of clinical points.
Risk Stratification

Score Interpretation & Clinical Stratification

Score RangeClinical InterpretationRisk Tier
≤ 1Low Riskgreen
1 – 2Low-Moderateyellow
2 – 3Moderateorange
≥ 3High Riskred
Normal Values / Reference Standard: A score of 0 represents a "Low Risk" (normal) state where anticoagulation is generally not indicated (except optionally in some female patients where female sex is the only risk factor).
Clinical Limitations & Contraindications

When to Exercise Caution

Not for use in patients with mechanical heart valves or moderate-to-severe mitral stenosis.

Sponsored Content
Medical Review & Guidelines Compliance
MD

Clinical Review Board

Dr. Muhammad Nouman, MBBS

Capital Medical University | PMDC Reg No: 117744-P

Clinical Audit Status

✓ Verified for 2026 Guidelines

Last updated: 2026-09-11

Peer-Reviewed Medical Literature

  • Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010.
Advertisement